Triphasic Randomized Clinical Trial: Comparison of effects on carbohydrate metabolism

American Journal of Obstetrics and Gynecology

Volumn 161, Issue 5, 1989, Pages 1402-1407

  Bowes Jr , Watson A ^a   Katta, Laura Rao ^b   Droegemueller, William ^a   Bright, Teresa G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

comparative trial; glucose; insulin; Oral contraceptives; triphasic

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; GLUCOSE; INSULIN; MESTRANOL; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; TRIPHASIC CONTRACEPTIVE AGENT;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BLOOD GLUCOSE; CARBOHYDRATES; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, SEQUENTIAL; FEMALE; HUMAN; INSULIN;

EID: 0024404874     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(89)90704-7     Document Type: Article

References (24)

1. Metabolic effects of Enovid in rheumatoid patients
2. A review of carbohydrate metabolism and the oral contraceptives
3. The effect of the progestogen ethynodiol, diacetate on glucose, insulin, and growth hormone after six months' treatment
4. Metabolic studies in women on norethindrone for 6 months' time (measurements of blood glucose insulin and triglyceride concentrations)
5. Norgestrel and carbohydrate-lipid metabolism: glucose, insulin and triglyceride changes during six months' time use
6. Effects of norethindrone on carbohydrate and lipid metabolism
7. Impaired glucose tolerance in women using oral contraceptives: United States, 1976–1980
8. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism
9. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases
10. Oral contraceptive and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins
11. Metabolic effects of the triphasic oral contraceptive Trigynon
12. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes
13. Evaluation of new triphasic oral contraceptive in private practice
14. Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study
15. Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism
16. A low-dose triphasic oral contraceptive
17. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months
18. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for three months
19. Effects of oral contraceptives on carbohydrate metabolism
20. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
21. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes